Personalized medicine: myth or reality? The position of Russian clinical pharmacologists

about

Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?Clinical pharmacology in Russia-historical development and current state.The Role of CYP1A1 Gene Polymorphism in Patients with Erysipelas

P2860

Q42731695-750AA659-09D0-4310-931A-1DEC157AEF9A Q48057372-E11EADE0-9CA1-4EFA-92D1-E0EB7767D990 Q58051696-567F02C3-452C-4B74-A329-C47C02DDCAD1

P2860

Personalized medicine: myth or reality? The position of Russian clinical pharmacologists

Item

http://www.wikidata.org/entity/Q37053383

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Personalized medicine: myth or reality? The position of Russian clinical pharmacologists

@en

Personalized medicine: myth or reality? The position of Russian clinical pharmacologists.

@nl

type

Item

label

Personalized medicine: myth or reality? The position of Russian clinical pharmacologists

@en

Personalized medicine: myth or reality? The position of Russian clinical pharmacologists.

@nl

prefLabel

Personalized medicine: myth or reality? The position of Russian clinical pharmacologists

@en

Personalized medicine: myth or reality? The position of Russian clinical pharmacologists.

@nl

P1476

Personalized medicine: myth or reality? The position of Russian clinical pharmacologists

@en

P2093

Anna S Zhestovskaja

http://www.w3.org/2001/XMLSchema#string

Dmitry A Sychev

http://www.w3.org/2001/XMLSchema#string

Vladimir G Kukes

http://www.w3.org/2001/XMLSchema#string

P2860

The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review

Individual response to drug therapy: bases and study approaches.

Physicochemical property trends of marketed prodrugs.

Study of urinary 6 beta-hydroxycortisol/cortisol ratio in spot urine sample as a biomarker of 3A4 enzyme activity in healthy and epileptic subjects of Egyptian population.

Systems pharmacology meets predictive, preventive, personalized and participatory medicine.

Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.

Cholesterol 25-hydroxylation activity of CYP3A.

Pinoline may be used as a probe for CYP2D6 activity.

Tolbutamide, flurbiprofen, and losartan as probes of CYP2C9 activity in humans.

Estimation of CYP2C19 activity by the omeprazole hydroxylation index at a single point in time after intravenous and oral administration.

P2888

1878-5085-4-13

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1878-5085-4-13

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236689362

http://www.w3.org/2001/XMLSchema#string

P6179

1012989468

http://www.w3.org/2001/XMLSchema#string

P698

23663439

http://www.w3.org/2001/XMLSchema#string

P932

3726329

http://www.w3.org/2001/XMLSchema#string

Personalized medicine: myth or reality? The position of Russian clinical pharmacologists

about

P2860

P2860

Personalized medicine: myth or reality? The position of Russian clinical pharmacologists

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P932